title: Letter by Krijnen et al regarding article, "The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial".
authors.forename: Paul A J
authors.initials: PA
authors.lastname: Krijnen
authors.forename: C Erik
authors.initials: CE
authors.lastname: Hack
authors.forename: Hans W M
authors.initials: HW
authors.lastname: Niessen
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D054058:Acute Coronary Syndrome / Q000201:enzymology*; D017130:Angioplasty / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D054497:Phospholipases A2, Secretory / Q000037:antagonists & inhibitors* / Q000378:metabolism*
chemical_list: D000085:Acetates; D007211:Indoles; D054497:Phospholipases A2, Secretory